Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation

Mukta Arora; Stephanie J. Lee; Stephen R. Spellman; Daniel J. Weisdorf; Weihua Guan; Mike Haagenson; Tao Wang; Mary H. Horowitz; Michael R. Verneris; Katharina Fleischhauer; Katharine Hsu; Bharat Thyagarajan

doi:10.1016/j.bbmt.2016.04.020

Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation

Mukta Arora, Stephanie J. Lee, Stephen R. Spellman, Daniel J. Weisdorf, Weihua Guan, Mike Haagenson, Tao Wang, Mary H. Horowitz, Michael R. Verneris, Katharina Fleischhauer, Katharine Hsu, Bharat Thyagarajan

Research output: Contribution to journal › Letter › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	1531-1532
Number of pages	2
Journal	Biology of Blood and Marrow Transplantation
Volume	22
Issue number	8
DOIs	https://doi.org/10.1016/j.bbmt.2016.04.020
State	Published - Aug 1 2016

Bibliographical note

Funding Information:
The CIBMTR is supported by Public Health Service Grant/Cooperative Agreement 5U24-CA076518 from the National Cancer Institute (NCI) , the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID) ; a Grant/Cooperative Agreement 5U10HL069294 from NHLBI and NCI ; a contract HHSH250201200016C with Health Resources and Services Administration (HRSA/DHHS) ; two grants N00014-15-1-0848 and N00014-16-1-2020 from the Office of Naval Research ; and grants from Alexion ; *Amgen, Inc. ; Anonymous donation to the Medical College of Wisconsin ; Astellas Pharma US ; AstraZeneca ; Be the Match Foundation ; ∗Bluebird Bio, Inc. ; ∗Bristol Myers Squibb Oncology ; ∗Celgene Corporation ; Cellular Dynamics International, Inc. ; ∗Chimerix, Inc. ; Fred Hutchinson Cancer Research Center ; Gamida Cell Ltd. ; Genentech, Inc. ; Genzyme Corporation ; ∗Gilead Sciences, Inc. ; Health Research, Inc. Roswell Park Cancer Institute ; HistoGenetics, Inc. ; Incyte Corporation ; Janssen Scientific Affairs, LLC ; ∗Jazz Pharmaceuticals, Inc. ; Jeff Gordon Children's Foundation ; The Leukemia & Lymphoma Society ; Medac, GmbH ; MedImmune ; The Medical College of Wisconsin ; ∗Merck & Co, Inc. ; Mesoblast ; MesoScale Diagnostics, Inc. ; ∗Miltenyi Biotec, Inc. ; National Marrow Donor Program ; Neovii Biotech NA, Inc. ; Novartis Pharmaceuticals Corporation ; Onyx Pharmaceuticals ; Optum Healthcare Solutions, Inc. ; Otsuka America Pharmaceutical, Inc. ; Otsuka Pharmaceutical Co, Ltd. – Japan ; PCORI ; Perkin Elmer, Inc. ; Pfizer, Inc ; ∗Sanofi US ; ∗Seattle Genetics ; ∗Spectrum Pharmaceuticals, Inc. ; St. Baldrick's Foundation ; ∗Sunesis Pharmaceuticals, Inc. ; Swedish Orphan Biovitrum, Inc. ; Takeda Oncology ; Telomere Diagnostics, Inc. ; University of Minnesota ; and ∗Wellpoint, Inc .

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.1016/j.bbmt.2016.04.020

Find It

Find It at U of M Libraries

Cite this

Arora, M., Lee, S. J., Spellman, S. R., Weisdorf, D. J., Guan, W., Haagenson, M., Wang, T., Horowitz, M. H., Verneris, M. R., Fleischhauer, K., Hsu, K., & Thyagarajan, B. (2016). Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation, 22(8), 1531-1532. https://doi.org/10.1016/j.bbmt.2016.04.020

Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation. / Arora, Mukta; Lee, Stephanie J.; Spellman, Stephen R. et al.
In: Biology of Blood and Marrow Transplantation, Vol. 22, No. 8, 01.08.2016, p. 1531-1532.

Research output: Contribution to journal › Letter › peer-review

Arora, M, Lee, SJ, Spellman, SR, Weisdorf, DJ , Guan, W, Haagenson, M, Wang, T, Horowitz, MH, Verneris, MR, Fleischhauer, K, Hsu, K & Thyagarajan, B 2016, 'Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation', Biology of Blood and Marrow Transplantation, vol. 22, no. 8, pp. 1531-1532. https://doi.org/10.1016/j.bbmt.2016.04.020

Arora M, Lee SJ, Spellman SR, Weisdorf DJ , Guan W, Haagenson M et al. Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 2016 Aug 1;22(8):1531-1532. doi: 10.1016/j.bbmt.2016.04.020

@article{b9e2ed57d4774b29a686cf86bcb35dad,

title = "Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation",

author = "Mukta Arora and Lee, {Stephanie J.} and Spellman, {Stephen R.} and Weisdorf, {Daniel J.} and Weihua Guan and Mike Haagenson and Tao Wang and Horowitz, {Mary H.} and Verneris, {Michael R.} and Katharina Fleischhauer and Katharine Hsu and Bharat Thyagarajan",

note = "Funding Information: The CIBMTR is supported by Public Health Service Grant/Cooperative Agreement 5U24-CA076518 from the National Cancer Institute (NCI) , the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID) ; a Grant/Cooperative Agreement 5U10HL069294 from NHLBI and NCI ; a contract HHSH250201200016C with Health Resources and Services Administration (HRSA/DHHS) ; two grants N00014-15-1-0848 and N00014-16-1-2020 from the Office of Naval Research ; and grants from Alexion ; *Amgen, Inc. ; Anonymous donation to the Medical College of Wisconsin ; Astellas Pharma US ; AstraZeneca ; Be the Match Foundation ; ∗Bluebird Bio, Inc. ; ∗Bristol Myers Squibb Oncology ; ∗Celgene Corporation ; Cellular Dynamics International, Inc. ; ∗Chimerix, Inc. ; Fred Hutchinson Cancer Research Center ; Gamida Cell Ltd. ; Genentech, Inc. ; Genzyme Corporation ; ∗Gilead Sciences, Inc. ; Health Research, Inc. Roswell Park Cancer Institute ; HistoGenetics, Inc. ; Incyte Corporation ; Janssen Scientific Affairs, LLC ; ∗Jazz Pharmaceuticals, Inc. ; Jeff Gordon Children's Foundation ; The Leukemia & Lymphoma Society ; Medac, GmbH ; MedImmune ; The Medical College of Wisconsin ; ∗Merck & Co, Inc. ; Mesoblast ; MesoScale Diagnostics, Inc. ; ∗Miltenyi Biotec, Inc. ; National Marrow Donor Program ; Neovii Biotech NA, Inc. ; Novartis Pharmaceuticals Corporation ; Onyx Pharmaceuticals ; Optum Healthcare Solutions, Inc. ; Otsuka America Pharmaceutical, Inc. ; Otsuka Pharmaceutical Co, Ltd. – Japan ; PCORI ; Perkin Elmer, Inc. ; Pfizer, Inc ; ∗Sanofi US ; ∗Seattle Genetics ; ∗Spectrum Pharmaceuticals, Inc. ; St. Baldrick's Foundation ; ∗Sunesis Pharmaceuticals, Inc. ; Swedish Orphan Biovitrum, Inc. ; Takeda Oncology ; Telomere Diagnostics, Inc. ; University of Minnesota ; and ∗Wellpoint, Inc . ",

year = "2016",

month = aug,

day = "1",

doi = "10.1016/j.bbmt.2016.04.020",

language = "English (US)",

volume = "22",

pages = "1531--1532",

journal = "Biology of Blood and Marrow Transplantation",

issn = "1083-8791",

publisher = "Elsevier Inc.",

number = "8",

}

TY - JOUR

T1 - Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation

AU - Arora, Mukta

AU - Lee, Stephanie J.

AU - Spellman, Stephen R.

AU - Weisdorf, Daniel J.

AU - Guan, Weihua

AU - Haagenson, Mike

AU - Wang, Tao

AU - Horowitz, Mary H.

AU - Verneris, Michael R.

AU - Fleischhauer, Katharina

AU - Hsu, Katharine

AU - Thyagarajan, Bharat

N1 - Funding Information: The CIBMTR is supported by Public Health Service Grant/Cooperative Agreement 5U24-CA076518 from the National Cancer Institute (NCI) , the National Heart, Lung and Blood Institute (NHLBI) and the National Institute of Allergy and Infectious Diseases (NIAID) ; a Grant/Cooperative Agreement 5U10HL069294 from NHLBI and NCI ; a contract HHSH250201200016C with Health Resources and Services Administration (HRSA/DHHS) ; two grants N00014-15-1-0848 and N00014-16-1-2020 from the Office of Naval Research ; and grants from Alexion ; *Amgen, Inc. ; Anonymous donation to the Medical College of Wisconsin ; Astellas Pharma US ; AstraZeneca ; Be the Match Foundation ; ∗Bluebird Bio, Inc. ; ∗Bristol Myers Squibb Oncology ; ∗Celgene Corporation ; Cellular Dynamics International, Inc. ; ∗Chimerix, Inc. ; Fred Hutchinson Cancer Research Center ; Gamida Cell Ltd. ; Genentech, Inc. ; Genzyme Corporation ; ∗Gilead Sciences, Inc. ; Health Research, Inc. Roswell Park Cancer Institute ; HistoGenetics, Inc. ; Incyte Corporation ; Janssen Scientific Affairs, LLC ; ∗Jazz Pharmaceuticals, Inc. ; Jeff Gordon Children's Foundation ; The Leukemia & Lymphoma Society ; Medac, GmbH ; MedImmune ; The Medical College of Wisconsin ; ∗Merck & Co, Inc. ; Mesoblast ; MesoScale Diagnostics, Inc. ; ∗Miltenyi Biotec, Inc. ; National Marrow Donor Program ; Neovii Biotech NA, Inc. ; Novartis Pharmaceuticals Corporation ; Onyx Pharmaceuticals ; Optum Healthcare Solutions, Inc. ; Otsuka America Pharmaceutical, Inc. ; Otsuka Pharmaceutical Co, Ltd. – Japan ; PCORI ; Perkin Elmer, Inc. ; Pfizer, Inc ; ∗Sanofi US ; ∗Seattle Genetics ; ∗Spectrum Pharmaceuticals, Inc. ; St. Baldrick's Foundation ; ∗Sunesis Pharmaceuticals, Inc. ; Swedish Orphan Biovitrum, Inc. ; Takeda Oncology ; Telomere Diagnostics, Inc. ; University of Minnesota ; and ∗Wellpoint, Inc .

PY - 2016/8/1

Y1 - 2016/8/1

UR - http://www.scopus.com/inward/record.url?scp=84973534412&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973534412&partnerID=8YFLogxK

U2 - 10.1016/j.bbmt.2016.04.020

DO - 10.1016/j.bbmt.2016.04.020

M3 - Letter

C2 - 27155583

AN - SCOPUS:84973534412

SN - 1083-8791

VL - 22

SP - 1531

EP - 1532

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

IS - 8

ER -

Validation Study Failed to Confirm an Association between Genetic Variants in the Base Excision Repair Pathway and Transplant-Related Mortality and Relapse after Hematopoietic Cell Transplantation

Bibliographical note

UN SDGs

Publisher link

Find It

Other files and links

Cite this